KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 99 filers reported holding KEROS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,300,015 | -20.5% | 72,146 | +0.2% | 0.00% | -25.0% |
| Q2 2023 | $2,892,639 | -3.5% | 71,992 | +2.6% | 0.00% | 0.0% |
| Q1 2023 | $2,996,857 | -11.1% | 70,184 | 0.0% | 0.00% | -20.0% |
| Q4 2022 | $3,370,235 | +2.5% | 70,184 | -19.7% | 0.01% | 0.0% |
| Q3 2022 | $3,288,363 | +887.5% | 87,410 | +1325.7% | 0.01% | +400.0% |
| Q1 2022 | $333,000 | -7.2% | 6,131 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $359,000 | +48.3% | 6,131 | +0.4% | 0.00% | – |
| Q3 2021 | $242,000 | -6.6% | 6,106 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $259,000 | -29.6% | 6,106 | +2.0% | 0.00% | 0.0% |
| Q1 2021 | $368,000 | -4.9% | 5,984 | +9.2% | 0.00% | 0.0% |
| Q4 2020 | $387,000 | – | 5,480 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,382,641 | $85,102,000 | 10.19% |
| Consonance Capital Management LP | 890,209 | $54,792,000 | 5.84% |
| CHI Advisors LLC | 400,468 | $24,649,000 | 4.94% |
| Fairmount Funds Management LLC | 109,333 | $6,729,000 | 2.84% |
| VR Adviser, LLC | 372,306 | $22,915,000 | 2.49% |
| Opaleye Management Inc. | 157,500 | $9,694,000 | 1.42% |
| Darwin Global Management, Ltd. | 86,887 | $5,348,000 | 1.05% |
| Orbimed Advisors | 1,679,417 | $103,368,000 | 0.97% |
| Nantahala Capital Management | 460,372 | $28,336,000 | 0.83% |
| Eventide Asset Management | 427,414 | $26,307,000 | 0.39% |